For years stifled by law, Texas’ modest medical cannabis industry is poised to boom in 2026 thanks to expanded patient eligibility and product access.
But as major marijuana multistate operators move to enter the Lone Star State for the first time, Texas’ estimated $5 billion hemp-derived THC market is still posing questions that both lawmakers and cannabis businesses will have to answer.
ADVERTISEMENT
For almost a decade, the only product available to the patients with epilepsy enrolled in the Texas Compassionate Use Program (TCUP) was very low THC oil obtained from only three licensed businesses, or dispensing organizations.
That led to criticism from cannabis advocates that TCUP, established in 2015, was so restrictive that it was practically worthless – for both patients as well
Read full article on Marijuana Business Daily
